James Basta - Jul 1, 2021 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
EVP, General Counsel
Signature
/s/ James Basta
Stock symbol
NTLA
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4
Date filed
7/6/2021, 04:44 PM
Previous filing
Jul 6, 2021
Next filing
Mar 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTLA Stock Option (Right to Buy) Award $0 +130K $0.00 130K Jul 1, 2021 Common Stock 130K $171.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 1, 2021 with respect to 130,000 shares of Common Stock, with 25% vesting on July 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.